Other: Glucose ( DrugBank: Glucose )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 254 | Porphyria | 1 |
254. Porphyria
Clinical trials : 70 / Drugs : 54 - (DrugBank : 19) / Drug target genes : 19 - Drug target pathways : 35
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02180412 (ClinicalTrials.gov) | April 28, 2014 | 25/6/2014 | Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria | A Double-blind, Randomized, Placebo-controlled, Parallel Group Trial on the Efficacy and Safety of PanhematinTM in the Treatment of Acute Attacks of Porphyria | Acute Porphyrias | Biological: Panhematin;Other: Glucose | The University of Texas Medical Branch, Galveston | NULL | Active, not recruiting | 18 Years | 100 Years | All | 40 | Phase 2 | United States |